| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916125 | Nuclear Medicine and Biology | 2012 | 11 Pages |
Abstract
177Lu-h-R3 should be considered for further evaluations as a potential radiopharmaceutical for RIT of tumors overexpressing EGFR.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Denis R. Beckford Vera, Sebastian Eigner, Katerina Eigner Henke, Ondrej Lebeda, Frantisek Melichar, Milos Beran,